Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Shaun C. Moore, Pedro A. S. Vaz de Castro, Daniel Yaqub, Pedro A. Jose & Ines Armando. (2023) Anti-Inflammatory Effects of Peripheral Dopamine. International Journal of Molecular Sciences 24:18, pages 13816.
Crossref
Crossref
Sitthiphon BunmanSombat Muengtaweepongsa, Dilok PiyayotaiRatthaphol CharlermrojKorawit KanjanaSudtida Kaew-amdeeManlika MakornwattanaSanghyun Kim. (2023) Analgesic and Anti-Inflammatory Effects of 1% Topical Cannabidiol Gel in Animal Models. Cannabis and Cannabinoid Research.
Crossref
Crossref
J.E. Sanchez, S. Noor, M.S. Sun, J. Zimmerly, A. Pasmay, J.J. Sanchez, A.G. Vanderwall, M.K. Haynes, L.A. Sklar, P.R. Escalona & E.D. Milligan. (2023) The FDA-approved compound, pramipexole and the clinical-stage investigational drug, dexpramipexole, reverse chronic allodynia from sciatic nerve damage in mice, and alter IL-1β and IL-10 expression from immune cell culture. Neuroscience Letters 814, pages 137419.
Crossref
Crossref
Jazmín Santamaria‐Anzures, Julia Pérez‐Ramos, Felipe Mendoza‐Pérez & Beatriz Godínez‐Chaparro. (2023) Pramipexole inhibits formalin‐induce acute and long‐lasting mechanical hypersensitivity via NF‐kB pathway in rats. Drug Development Research 84:2, pages 253-261.
Crossref
Crossref
Sitthiphon Bunman, Sombat Muengtaweepongsa, Dilok Piyayotai, Ratthaphol Charlermroj, Korawit Kanjana, Sudtida Kaew-amdee, Manlika Makornwattana & Sanghyun Kim. (2023) Anti-inflammatory effects of oral cannabidiol in rat models. F1000Research 12, pages 680.
Crossref
Crossref
An-qi Dong, Ya-ping Yang, Shu-min Jiang, Xiao-yu Yao, Di Qi, Cheng-jie Mao, Xiao-yu Cheng, Fen Wang, Li-fang Hu & Chun-feng Liu. (2022) Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease. Acta Pharmacologica Sinica 44:1, pages 32-43.
Crossref
Crossref
Poonam Negi, Shweta Agarwal, Prakrati Garg, Aaliya Ali & Saurabh Kulshrestha. 2023. Recent Developments in Anti-Inflammatory Therapy. Recent Developments in Anti-Inflammatory Therapy
315
330
.
Nayira A. Abdel Baky, Aya H. Al-Najjar, Hemat A. Elariny, Amany Said Sallam & Asmaa A. Mohammed. (2022) Pramipexole and Lactoferrin ameliorate Cyclophosphamide-Induced haemorrhagic cystitis via targeting Sphk1/S1P/MAPK, TLR-4/NF-κB, and NLRP3/caspase-1/IL-1β signalling pathways and modulating the Nrf2/HO-1 pathway. International Immunopharmacology 112, pages 109282.
Crossref
Crossref
Mohd. Salman, Mohd. Akram, Mohd. Shahrukh, Tauheed Ishrat & Suhel Parvez. (2022) Effects of pramipexole on beta-amyloid1–42 memory deficits and evaluation of oxidative stress and mitochondrial function markers in the hippocampus of Wistar rat. NeuroToxicology 92, pages 91-101.
Crossref
Crossref
Hadeel A. Fawzy, Asmaa A. Mohammed, Hala M. Fawzy & Ebtehal M. Fikry. (2022) Reorienting of pramipexole as a promising therapy for acute pancreatitis in a rat model by suppressing TLR4\NF-κB p65\NLRP3 inflammasome signaling. Canadian Journal of Physiology and Pharmacology 100:6, pages 542-552.
Crossref
Crossref
Changming Tan, Zhaoshun Yuan, Feng Xu & Xia Xie. (2022) Electrospun cellulose acetate wound dressings loaded with Pramipexole for diabetic wound healing: an in vitro and in vivo study. Cellulose 29:6, pages 3407-3422.
Crossref
Crossref
Catarina Gonçalves, Daniela Fernandes, Inês Silva & Vanessa Mateus. (2022) Potential Anti-Inflammatory Effect of Rosmarinus officinalis in Preclinical In Vivo Models of Inflammation. Molecules 27:3, pages 609.
Crossref
Crossref
Sen Jiang, Hua Gao, Yuxuan Yong, Huaxiong Zhang, Peishan Li, Yanxia Li, Qin Luo & Xinling Yang. (2022) Effect of Pramipexole on Inflammatory Response in Central Nervous System of Parkinson's Disease Rat Model. Archives of Medical Research 53:1, pages 37-43.
Crossref
Crossref
Alberto Sanchez, Ingrid Morales, Clara Rodriguez-Sabate, Miguel Sole-Sabater & Manuel Rodriguez. (2021) Astrocytes, a Promising Opportunity to Control the Progress of Parkinson’s Disease. Biomedicines 9:10, pages 1341.
Crossref
Crossref
Javier Campos & Rodrigo Pacheco. (2020) Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammation. Seminars in Immunopathology 42:6, pages 681-696.
Crossref
Crossref
Raquel Espinosa-Cárdenas, Asiel Arce-Sillas, Diana Álvarez-Luquin, Jaquelin Leyva-Hernández, Esteban Montes-Moratilla, Israel González-Saavedra, Marie Catherine Boll, Elizabeth Garcia-Garcia, Sandra Ángeles-Perea, Gladis Fragoso, Edda Sciutto & Laura Adalid-Peralta. (2020) Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: A two-year prospective study. Journal of Neuroimmunology 347, pages 577328.
Crossref
Crossref
Mohd. Salman, Heena Tabassum & Suhel Parvez. (2020) Nrf2/HO-1 mediates the neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats. Disease Models & Mechanisms 13:8.
Crossref
Crossref
Humeyra Nur Kaleli, Ebru Ozer, Veysel Ogulcan Kaya & Ozlem Kutlu. (2020) Protein Kinase C Isozymes and Autophagy during Neurodegenerative Disease Progression. Cells 9:3, pages 553.
Crossref
Crossref
Héctor Alonso Romero-Sánchez, Liliana Mendieta, Amaya Montserat Austrich-Olivares, Gabriela Garza-Mouriño, Marcela Benitez-Diaz Mirón, Arrigo Coen & Beatriz Godínez-Chaparro. (2020) Unilateral lesion of the nigroestriatal pathway with 6-OHDA induced allodynia and hyperalgesia reverted by pramipexol in rats. European Journal of Pharmacology 869, pages 172814.
Crossref
Crossref
Chao Deng, Jianping Zhu, Junlan Yuan, Yong Xiang & Li Dai. (2019) Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF. Neurochemical Research 45:2, pages 268-277.
Crossref
Crossref
I. Kostadinov, A. Mihaylova, H. Zlatanova, N. Doncheva, D. Delev & M. Ivanovska. (2019) P.414 Influence of the dopamine receptor agonist pramipexole on serum levels of pro- and anti-inflammatory cytokines. European Neuropsychopharmacology 29, pages S293-S294.
Crossref
Crossref
Kalpesh R. Patil, Umesh B. Mahajan, Banappa S. Unger, Sameer N. Goyal, Sateesh Belemkar, Sanjay J. Surana, Shreesh Ojha & Chandragouda R. Patil. (2019) Animal Models of Inflammation for Screening of Anti-inflammatory Drugs: Implications for the Discovery and Development of Phytopharmaceuticals. International Journal of Molecular Sciences 20:18, pages 4367.
Crossref
Crossref
Felipe Patricio, Irving Parra, Isabel Martínez, Francisca Pérez-Severiano, Sergio Montes, José Aguilera, Ilhuicamina Daniel Limón, Yousef Tizabi & Liliana Mendieta. (2019) Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson’s Disease. Neurotoxicity Research 35:3, pages 699-710.
Crossref
Crossref
Ren-Hong Du, Yan Zhou, Mei-Ling Xia, Ming Lu, Jian-Hua Ding & Gang Hu. (2018) α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes. Journal of Neuroinflammation 15:1.
Crossref
Crossref
Samira Koroji, Ali A. Mohammadi & Mohammad Mehrshad. (2018)
An Efficient One-Pot Three-Component Synthesis of Some New 3-(Benzo[
d
]thiazol-2-yl)-2-alkyl-4(3
H
)-quinazolinones Using Silica Sulfuric Acid as a Heterogeneous Catalyst
. Journal of Heterocyclic Chemistry 55:11, pages 2647-2651.
Crossref
Crossref